You just read:

REGENXBIO Expands Pipeline Using NAV Vectors to Deliver Therapeutic Antibodies for the Treatment of Hereditary Angioedema and Neurodegenerative Diseases

News provided by

REGENXBIO Inc.

Jul 24, 2019, 16:10 ET